FACTORS ASSOCIATED WITH DEVELOPMENT OF MENTAL ILLNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A POPULATION-BASED STUDY

被引:0
|
作者
Chen, H. H. [1 ,2 ]
Chao, W. C. [1 ,3 ]
机构
[1] Natl Chung Hsing Univ, Dept Postbaccalaureate Med, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Dept Crit Care Med, Taichung, Taiwan
关键词
Targeted synthetic drugs; bDMARD; Mental health;
D O I
10.1136/annrheumdis-2023-eular.1176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0289
引用
收藏
页码:1326 / 1326
页数:1
相关论文
共 50 条
  • [21] Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
    Terabe, Kenya
    Takahashi, Nobunori
    Asai, Shuji
    Hirano, Yuji
    Kanayama, Yasuhide
    Yabe, Yuichiro
    Oguchi, Takeshi
    Fujibayashi, Takayoshi
    Ishikawa, Hisato
    Hanabayashi, Masahiro
    Hattori, Yosuke
    Suzuki, Mochihito
    Kishimoto, Kenji
    Ohashi, Yoshifumi
    Imaizumi, Takahiro
    Imagama, Shiro
    Kojima, Toshihisa
    MODERN RHEUMATOLOGY, 2023, 33 (02) : 292 - 301
  • [22] Factors Associated with the Initiation of Biologic Disease-Modifying Antirheumatic Drugs in Texas Medicaid Patients with Rheumatoid Arthritis
    Kim, Gilwan
    Barner, Jamie C.
    Rascati, Karen
    Richards, Kristin
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (05): : 401 - 407
  • [23] POSTOPERATIVE COMPLICATIONS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGIC AND NONBIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Pogozheva, E.
    Amirdzhanova, V.
    Makarov, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 374 - 375
  • [24] PERSISTENCE WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS - A RETROSPECTIVE DATABASE STUDY IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS
    Mahlich, J.
    Kameda, H.
    Sruamsiri, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 440 - 440
  • [25] THE VALUE OF TIMELY BIOLOGIC OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS THERAPY IN THE DEVELOPMENT OF OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE
    Matianova, E. V.
    Gordeev, A. V.
    Galushko, E. A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S379 - S379
  • [26] THE COURSE OF COVID-19 INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING VARIOUS BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Samigullina, R.
    Dadalova, A.
    Vasilenko, E.
    Mazurov, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1711 - 1711
  • [27] Impact of Initiating Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs on Pain Medication Use in Patients with Rheumatoid Arthritis
    He, Mengdong
    Lee, Yvonne
    Jin, Yinzhu
    Desai, Rishi
    Vine, Seanna
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1828 - 1830
  • [28] Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs
    Mori, Shunsuke
    MODERN RHEUMATOLOGY, 2011, 21 (06) : 621 - 627
  • [29] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
    Smolen, Josef S.
    Landewe, Robert B. M.
    Bergstra, Sytske Anne
    Kerschbaumer, Andreas
    Sepriano, Alexandre
    Aletaha, Daniel
    Caporali, Roberto
    Edwards, Christopher John
    Hyrich, Kimme L.
    Pope, Janet E.
    de Souza, Savia
    Stamm, Tanja A.
    Takeuchi, Tsutomu
    Verschueren, Patrick
    Winthrop, Kevin L.
    Balsa, Alejandro
    Bathon, Joan M.
    Buch, Maya H.
    Burmester, Gerd R.
    Buttgereit, Frank
    Cardiel, Mario Humberto
    Chatzidionysiou, Katerina
    Codreanu, Catalin
    Cutolo, Maurizio
    den Broeder, Alfons A.
    El Aoufy, Khadija
    Finckh, Axel
    Fonseca, Joao Eurico
    Gottenberg, Jacques-Eric
    Haavardsholm, Espen A.
    Iagnocco, Annamaria
    Lauper, Kim
    Li, Zhanguo
    McInnes, Iain B.
    Mysler, Eduardo F.
    Nash, Peter
    Poor, Gyula
    Ristic, Gorica G.
    Rivellese, Felice
    Rubbert-Roth, Andrea
    Schulze-Koops, Hendrik
    Stoilov, Nikolay
    Strangfeld, Anja
    van der Helm-van Mil, Annette
    van Duuren, Elsa
    Vliet Vlieland, Theodora P. M.
    Westhovens, Rene
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01) : 3 - 18
  • [30] Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
    Mittal, Niti
    Mittal, Rakesh
    Sharma, Aman
    Jose, Vinu
    Wanchu, Ajay
    Singh, Surjit
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 532 - 536